COVID-19 in the years 2020 to 2022 in Germany: effects of comorbidities and co-medications based on a large-scale database analysis

Abstract Background The SARS-CoV-2 pandemic was a challenge for health care systems worldwide. People with pre-existing chronic diseases have been identified as vulnerable patient groups. Furthermore, some of the drugs used for these chronic diseases such as antihypertensive drugs have been discusse...

Full description

Saved in:
Bibliographic Details
Main Authors: Roland Linder, Jonas Peltner, Anatoli Astvatsatourov, Willy Gomm, Britta Haenisch
Format: Article
Language:English
Published: BMC 2025-02-01
Series:BMC Public Health
Subjects:
Online Access:https://doi.org/10.1186/s12889-024-21110-7
Tags: Add Tag
No Tags, Be the first to tag this record!